Feed SHEZF
SH
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. SHEZF OTC · Healthcare · China
$0.47 +0.00% +$0.00
Depth
- Market cap
- ¥4.59B
- Enterprise value
- ¥6.00B
- P/E
- 24.2x
- Forward P/E
- 6.4x
- PEG
- -
- P/S
- 0.9x
- P/FCF
- 2.8x
- EV/EBITDA
- 12.5x
- ROIC
- 1.0%
- Gross margin
- 34.0%
- Net margin
- 3.7%
- Dividend yield
- 4.51%
- Payout ratio
- 109.3%
- Net debt/EBITDA
- 2.9x
- Beta
- 0.31
- Free float
- 27.3%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Li Li
Employees
1,926
Headquarters
Shenzhen
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
- What to watch: Revenue fell by 8.5% a year over the last 3 years.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 CNY of revenue, 33 CNY is left as free cash.
- What to watch: It earns only 1.0 CNY a year on every 100 CNY of invested capital.
- What to watch: Out of every 100 CNY of revenue, only 3.7 CNY is left as net profit.
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
- What to watch: It pays out more in dividends than it earns: 109% of profit.
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
- What speaks for it: The price moves less than the market (beta 0.31).
Statements
Every number